Could a stool sample someday help clinicians choose a diabetes medication before writing the prescription? Emerging research into gut biomarkers in diabetes is moving that possibility closer to clinical reality. Rather than simply cataloging which bacteria live in the intestine, researchers are examining microbial genes, stool-derived metabolites, and functional signatures …
Read More »The Return of Aldose Reductase Inhibitors: Could an Old Idea Finally Pay Off?
Diabetes care has advanced dramatically over the past decade. While therapies such as GLP-1 receptor agonists and SGLT2 inhibitors have transformed glucose management and cardiovascular outcomes, many patients continue to develop long-term complications. Could an older therapeutic target finally provide the missing piece? Interest in aldose reductase inhibitors for diabetes …
Read More »Can Turning Body Fat Into a Metabolic Powerhouse Change Diabetes Treatment?
For decades, diabetes research has focused on protecting insulin-producing beta cells or replacing those that have been lost. However, scientists are now exploring a completely different strategy. Instead of repairing the pancreas, researchers are investigating whether the body’s own fat can become a powerful tool for improving glucose control. This …
Read More »Could Tiny RNA Molecules Transform the Future of Diabetes Care?
Diabetes research is moving beyond blood sugar measurements and insulin therapy into an exciting new frontier. One of the most promising areas involves microRNAs, tiny RNA molecules that quietly regulate hundreds of genes throughout the body. Although they are microscopic, their influence on insulin production, inflammation, and blood vessel health …
Read More »Why Scientists Are Taking Another Look at the BCG Vaccine for Type 1 Diabetes
For more than 100 years, the Bacillus Calmette-Guérin (BCG) vaccine has been used worldwide to help prevent tuberculosis. However, researchers are now exploring another possible role for this familiar vaccine. Recent studies suggest that the BCG vaccine may play a role in treating type 1 diabetes by modifying the immune …
Read More »Could We Predict Diabetic Neuropathy Years Before Symptoms Begin?
Early detection has always been one of the biggest challenges in diabetes care. What if doctors could identify patients at high risk for diabetic neuropathy or kidney disease years before symptoms developed? That possibility is driving exciting new research into IgG glycosylation in diabetes, an emerging area that examines subtle …
Read More »A Newly Discovered Form of Cell Death May Explain Why Diabetes Causes So Many Complications
Diabetes is known for raising blood sugar levels, but its long-term complications often have the greatest impact on health. Kidney disease, vision loss, nerve damage, and cardiovascular disease affect millions of people living with diabetes. For years, researchers focused on inflammation, oxidative stress, and poor circulation to explain these complications. …
Read More »The Blood Vessel Damage Doctors Can’t See—Until It’s Too Late
Most people think diabetes-related blood vessel damage begins only after years of high blood sugar. However, scientists are uncovering evidence that injury may start much earlier, in a structure so thin it cannot be seen during a routine medical exam. This microscopic layer, known as the endothelial glycocalyx, acts as …
Read More »Could Too Much Protein Be Affecting Insulin? Scientists Take a Closer Look
New research is changing the conversation around protein and metabolic health. For years, high-protein diets have been praised for supporting weight loss, preserving muscle, and improving blood sugar control. However, scientists are now discovering that the story may be more complex. Rather than blaming protein itself, researchers are focusing on …
Read More »Not All Diabetic Kidney Disease Is the Same—Scientists Just Found a Hidden Subtype
For years, diabetic kidney disease (DKD) has been viewed as a single condition that progresses in a fairly predictable way. However, new research suggests that this assumption may overlook important biological differences between patients. Scientists have now identified a previously hidden subtype of diabetic kidney disease marked by increased B-cell …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.